HOLBROOK, N.Y., June 5, 2014 /PRNewswire/ -- Northstar
Global Business Services, Inc., Symbol (OTCPink: MDIN) today
announced that it has executed an agreement with Kush Creams, one
of the leading Medical marijuana growers and distributors based out
of Washington state, to not only
manufacture Northstar's first medical marijuana product, Snorenz
Medicated©, but also to distribute the product to marijuana
dispensaries throughout the State.
The deal has Kush Creams starting a significant manufacturing
run immediately, in order to have enough inventory for the initial
orders. It is expected that approximately a hundred dispensaries
will start out carrying Snorenz Medicated, and that number is
expected to grow significantly as the product begins to capitalize
on Snorenz's existing brand awareness. Once dispensaries that
already carry various Kush Creams products see that Snorenz
Medicated is available, it is fully expected that the penetration
of the market will increase very quickly.
Northstar maintains that its research has shown that many legal
marijuana users are already taking some form of Marijuana at night
in order to relax and sleep better. Adding THC (the chemical
compound contained in marijuana that causes intoxication) to the
popular Snorenz formula, not only delivers a good dose of THC, but
also lubricates the throat, helping with the "dry mouth" often
associated with marijuana, as well as the normal anti-snoring
benefits that have made Snorenz Northstar's biggest seller.
"We think this is a home run for Northstar. Not only are we
getting a foot in the door of an emerging industry that measures in
the tens of billions of dollars per year, but we are also tapping
into a very specific and dedicated demographic to introduce our
anti-snoring products in a way that will help grow the brand," said
Justin Sindelman, Northstar's CEO.
Sindelman went on to say, "Snorenz customers will greatly benefit
from the added effects of THC. The fact that we are infusing an
already popular product with the potent power of THC, and not
creating just another Marijuana product, is the precise reason why
this is groundbreaking. I think we are really making history, and
leading the way for all supplement and food product companies that
feel they have something to contribute to this explosive
market."
Shareholders can hear more about the new products and the
partnership with Kush creams on Monday June 23rd, at
6:30 PM EDT on the Pot Stock Radio.
Mr. Sindelman will be interviewed along with Megan Schwarting from Kush Creams. Both
companies look forward to giving everyone a little insight on the
strategy, business model and goals moving forward.
About Northstar
Northstar Global Business Services is dedicated to producing the
best alternative healthcare products to the world. The company's
products include Snorenz®, Good Night's Sleep®, Stem-Intense, and
more. Most of the company's products use a unique or patented spray
delivery system, and all have received rave consumer reviews all
over the world, selling millions of units from 1996 to the present.
www.medgeninc.com.
About Kush Creams:
Kush Creams is a nationwide leader and industry pioneer in medical
cannabis topical pain relief. Founded in 2010 in Washington state, the company has quickly and
successfully grown to serve the the thriving medical marijuana
marketplace and the newly emerging legal cannabis market. Kush
Creams currently manufactures an extensive line of over the counter
and prescription strength products and has won over a dozen
industry awards. www.kushcreams.com.
DISCLAIMER
This Press Release may contain certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. The Company has tried, whenever possible, to identify
these forward-looking statements using words such as "anticipates,"
"believes," "estimates," "expects," "plans," "intends," "potential"
and similar expressions. These statements reflect the Company's
current beliefs and are based upon information currently available
to it. Accordingly, such forward-looking statements involve known
and unknown risks, uncertainties and other factors which could
cause the Company's actual results, performance or achievements to
differ materially from those expressed in or implied by such
statements. The Company undertakes no obligation to update or
advise in the event of any change, addition or alteration to the
information catered in this Press Release including such
forward-looking statements.
Investor Relations
Investors@medgeninc.com
877-571-4387
SOURCE Northstar Global Business Services, Inc.